Cryptosporidiosis: an emerging, highly infectious threat
about
Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody.MicroRNAs in the Host-Apicomplexan Parasites Interactions: A Review of Immunopathological AspectsCryptosporidium pathogenicity and virulenceIdentification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiaeIdentification and characterization of a novel calcium-activated apyrase from Cryptosporidium parasites and its potential role in pathogenesisTargeting purine and pyrimidine metabolism in human apicomplexan parasitesAssociation between Cryptosporidium infection and human leukocyte antigen class I and class II allelesCryptosporidium infection causes undernutrition and, conversely, weanling undernutrition intensifies infection.HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum.Investigation of Swedish cases reveals an outbreak of cryptosporidiosis at a Norwegian hotel with possible links to in-house water systems.Putative cis-regulatory elements associated with heat shock genes activated during excystation of Cryptosporidium parvum.Sequence polymorphism in the beta-tubulin gene reveals heterogeneous and variable population structures in Cryptosporidium parvumFoodborne and waterborne infectious diseases. Contributing factors and solutions to new and reemerging pathogens.Burden of diarrhea, hospitalization and mortality due to cryptosporidial infections in Indian children.Quantitative flow cytometric evaluation of maximal Cryptosporidium parvum oocyst infectivity in a neonate mouse modelSources and species of cryptosporidium oocysts in the Wachusett Reservoir watershedAnalysis of sequence diversity at the highly polymorphic Cpgp40/15 locus among Cryptosporidium isolates from human immunodeficiency virus-infected children in South Africa.Cryptosporidiosis, whether it is more prevalent in Southern IndiaThe emerging nosocomial pathogens Cryptosporidium, Escherichia coli O157:H7, Helicobacter pylori, and hepatitis C: epidemiology, environmental survival, efficacy of disinfection, and control measures.Communitywide cryptosporidiosis outbreak associated with a surface water-supplied municipal water system--Baker City, Oregon, 2013.MicroRNA-221 controls expression of intercellular adhesion molecule-1 in epithelial cells in response to Cryptosporidium parvum infection.Structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from cryptosporidium.Transient neonatal Cryptosporidium parvum infection triggers long-term jejunal hypersensitivity to distension in immunocompetent rats.The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism.Paradoxical helminthiasis and giardiasis in Cape Town, South Africa: epidemiology and control.Sporadic cryptosporidiosis decline after membrane filtration of public water supplies, England, 1996-2002Sporadic cryptosporidiosis, North Cumbria, England, 1996-2000.Two crystal structures of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveal protein-ligand interactions including a structural basis for observed antifolate resistance.Rapid displacement of Cryptosporidium parvum type 1 by type 2 in mixed infections in piglets.Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice.Global change, parasite transmission and disease control: lessons from ecology.CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages.A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection.Human intestinal and biliary cryptosporidiosis.The SEEDs of two gastrointestinal diseases: socioeconomic, environmental, and demographic factors related to cryptosporidiosis and giardiasis in Massachusetts.A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infectionOutbreaks where food workers have been implicated in the spread of foodborne disease. Part 4. Infective doses and pathogen carriage.Disruption of the crossover helix impairs dihydrofolate reductase activity in the bifunctional enzyme TS-DHFR from Cryptosporidium hominis.Cryptosporidium parvum DNA replication in cell-free culture.Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes.
P2860
Q24515033-FBCBF130-951F-4959-B164-C8DBA64E4835Q26766336-5E53A3E3-C920-4245-8DC6-FC3C10796ED8Q26823336-A4BF9D83-E507-4545-9BB7-294229B77744Q28344053-268C448C-8A17-4B1C-8854-6F06D2487B82Q28480865-03BB6B62-2654-4632-BFCC-BA0B9C09A536Q28629739-FA8BD4B9-BB44-4873-BF4B-58699062B7F8Q30425869-6D1AAD89-B16F-4765-A08C-E290E9C8B3C2Q30432779-BACE6B23-B6B0-4597-B7EB-F3D1D9597186Q30436450-4BE0FDE7-0C8D-4D77-88F2-6671FDDB1746Q33381884-2B8FF363-714D-4EED-B675-98C3D43C531BQ33538023-98D21201-EED2-4550-A039-5F2DD56A31E3Q33719152-95860287-73DA-4954-A0A4-D428DCAA7F8AQ33897731-96207680-DA6E-4F8D-880F-31577430B7E5Q33945661-CF150131-5C7F-4CED-BA3B-BA1D6067B658Q33987782-C3C1F75F-5E47-4FDA-991F-E7DBC36FC4DAQ34100130-53C2CB6C-7FF8-4065-8FE1-7B5821CBA157Q34126345-5D3E8AF3-25FF-4A01-A04E-3B72040E400DQ34201328-CEBF85B3-2804-4FBC-81CE-0AFA567C905FQ34294486-9D4C8EA3-A382-4711-A876-471DADF29E81Q34489160-067DEEE0-4D23-4C23-8760-DAE3B244A579Q34612466-57CB8524-7268-43C8-92C5-FAE3E4F66B15Q34657298-943DE59B-2DFA-498A-A878-B64A53C59D40Q34721062-F7F13C7B-3703-434C-A1CE-916118054BEEQ35689260-F4412E88-C291-4111-9CB3-52D79E10E0E8Q35697923-CF3B028D-BA15-475A-A40A-6B0851EB0193Q35873344-3CC19E84-18EE-4A5D-B66B-324C765D0D8EQ35880437-859D8396-FE1A-42F7-9257-8469F22EFC21Q35950588-BE12611F-CBF7-4941-9EDD-457EB5832CFCQ36046487-7A9CCF56-2705-404D-83F9-561B1036091CQ36097893-71E285DE-0908-4A77-94B5-7C059FC462A5Q36306897-D7F9BD18-4011-4062-BD10-8A167DF48448Q36367680-6855A661-E588-448A-9BCF-6904F7D2D121Q36372711-A0E4BD39-3093-4C44-8FA7-A8CD197C2A91Q36397124-FCC756E7-57C1-4CC2-8A47-16824EDDE0CCQ37313931-3C2C60E5-8107-4646-97E8-5DC5A4BEFDA6Q37335883-A7B6615D-2862-4578-8D99-F47C9893392DQ37338127-A8EF8D48-60A4-4A42-BAEC-307C2323B03AQ37403841-905E68E9-7180-4C34-AFC2-F7EFE766D516Q37441235-213F11F2-E5AC-4C74-830D-2DFA31B27D5EQ37523679-BA955483-9662-407C-AC50-5A189C61DCC8
P2860
Cryptosporidiosis: an emerging, highly infectious threat
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Cryptosporidiosis: an emerging, highly infectious threat
@ast
Cryptosporidiosis: an emerging, highly infectious threat
@en
type
label
Cryptosporidiosis: an emerging, highly infectious threat
@ast
Cryptosporidiosis: an emerging, highly infectious threat
@en
prefLabel
Cryptosporidiosis: an emerging, highly infectious threat
@ast
Cryptosporidiosis: an emerging, highly infectious threat
@en
P2860
P356
P1476
Cryptosporidiosis: an emerging, highly infectious threat
@en
P2093
R L Guerrant
P2860
P356
10.3201/EID0301.970106
P577
1997-01-01T00:00:00Z